Share on StockTwits

Cemex SAB de CV (NYSE:CX) was the target of a large decline in short interest in June. As of June 13th, there was short interest totalling 89,527,452 shares, a decline of 4.0% from the May 30th total of 93,284,326 shares, AmericanBankingNews.com reports. Approximately 7.4% of the company’s shares are short sold. Based on an average daily volume of 9,584,575 shares, the short-interest ratio is presently 9.3 days.

CX has been the subject of a number of recent research reports. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Cemex SAB de CV in a research note on Friday, June 27th. They now have a $15.50 price target on the stock, up previously from $14.00. Analysts at Jefferies Group reiterated a “hold” rating on shares of Cemex SAB de CV in a research note on Thursday, June 19th. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. Cemex SAB de CV currently has a consensus rating of “Buy” and a consensus target price of $14.50.

Cemex SAB de CV (NYSE:CX) opened at 13.47 on Tuesday. Cemex SAB de CV has a one year low of $9.4327 and a one year high of $13.8173. The stock has a 50-day moving average of $13.08 and a 200-day moving average of $12.42. The company’s market cap is $16.559 billion.

Cemex SAB de CV (NYSE:CX) last announced its earnings results on Wednesday, April 30th. The company reported ($0.24) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.17) by $0.07. The company had revenue of $3.59 million for the quarter, compared to the consensus estimate of $3.46 billion. On average, analysts predict that Cemex SAB de CV will post $-0.19 earnings per share for the current fiscal year.

CEMEX SAB de CV (NYSE:CX) is a Mexico-based company principally engaged, through its subsidiaries, in the cement manufacturing.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.